Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Chronic Renal Failure

Free Subscription Articles published in Nephrol Dial Transplant Retrieve available abstracts of 105 articles: HTML format

Single Articles

May 2025
1. MORALES E, Martin WP, Bevc S, Jenssen TG, et al
   How to individualise renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.
   Nephrol Dial Transplant. 2025 May 13:gfaf069. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. ZOCCALI C, Lameire N, Ronco C, Carlson N, et al
   Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives.
   Nephrol Dial Transplant. 2025 May 12:gfaf090. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. GLASSOCK RJ, Rule AD, Denic A, Delanaye P, et al
   KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective.
   Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093.
   PubMed    
   
   
   
4. 
   Correction to: Global health inequalities of chronic kidney disease: a meta-analysis.
   Nephrol Dial Transplant. 2025 May 6:gfaf080. doi: 10.1093.
   PubMed    
   
   
   April 2025
5. QUENNEPOIX M, Koppe L, Bevier A, Barba C, et al
   Comparison of different heparin-free dialysis methods.
   Nephrol Dial Transplant. 2025 Apr 30:gfaf082. doi: 10.1093.
   PubMed    
   
   
   
6. SCHMIDT-LAUBER C, Thompson C, Schmidt EA, Klopp A, et al
   Prevalence and Characteristics of Chronic Kidney Disease in the Hamburg City Health Study.
   Nephrol Dial Transplant. 2025 Apr 30:gfaf075. doi: 10.1093.
   PubMed    
   
   
   
7. DOLAN KJ, Gist KM, Basalely A, Bottari G, et al
   Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry.
   Nephrol Dial Transplant. 2025 Apr 21:gfaf067. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. MONTEZ DE SOUSA IR, Bonthuis M, Kramer A, Ordonez FA, et al
   Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
   Nephrol Dial Transplant. 2025;40:707-719.
   PubMed     Abstract available
   
   
   March 2025
9. ZHAO Y, Yang K, Nguyen CM, Wu H, et al
   Sex-specific cardiac dysfunction in mice with chronic kidney disease.
   Nephrol Dial Transplant. 2025 Mar 21:gfaf056. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. FERRO CJ, Wanner C, Luyckx V, Stevens K, et al
    ABCDE to identify and prevent chronic kidney disease: a call to action.
    Nephrol Dial Transplant. 2025 Mar 19:gfaf057. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. ANDRADE A, Bachmann M, Bobot M, Bruchfeld A, et al
    Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
12. PEPIN M, Giannakou K, Levassort H, Farinha A, et al
    Care pathways for patients with cognitive impairment and chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
13. ZHANG Y, Ye Z, Zhang Y, Yang S, et al
    Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf052. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. BAKKER WM, Heerspink HJL, Berger SP, Wanner C, et al
    Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf046. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
15. URO-COSTE C, Lambert C, Audard V, Couzi L, et al
    Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
    Nephrol Dial Transplant. 2025;40:475-483.
    PubMed     Abstract available
    
    
    
16. KANDURI SR, Badari A, Ullah F, Yang CW, et al
    Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf028. doi: 10.1093.
    PubMed    
    
    
    
17. XU H, Eriksdotter M, Hafez G, Mitra S, et al
    Cholinergic system in patients with chronic kidney disease: cognitive and renal implications.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
    COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf022. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. WAGNER CA
    Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
20. ALICIC RZ, Neumiller JJ, Tuttle KR
    Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
21. NEUEN BL, Yeung EK, Rangaswami J, Vaduganathan M, et al
    Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
22. ZHU D, Judge PK, Staplin N, Haynes R, et al
    Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
23. NARDONE M, Yau K, Kugathasan L, Odutayo A, et al
    Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
24. MOEDT E, Wasehuus VS, Heerspink HJL
    Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
25. CHEIKH HASSAN H, Tunnicliffe DJ, Loyd L, Mullan A, et al
    Kidney failure from kidney stones: an ANZDATA study.
    Nephrol Dial Transplant. 2025;40:320-328.
    PubMed     Abstract available
    
    
    January 2025
26. JORGENSEN HS, Vervloet M, Cavalier E, Bacchetta J, et al
    The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.
    Nephrol Dial Transplant. 2025 Jan 28:gfae293. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. TORINO C, Mallamaci F, Tripepi R, Mezzatesta S, et al
    The use of lung-ultrasound monitoring and the risk of intradialysis hypotension in hemodialysis patients: an analysis in the context of a randomized clinical trial.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf015. doi: 10.1093.
    PubMed    
    
    
    
28. ZOCCALI C, Mallamaci F, Kanbay M, Tuttle KR, et al
    The Autonomic Nervous System and Inflammation in Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. YEN FS, Wei JC, Cheng WY, Huang CT, et al
    Low birth weight and chronic kidney disease with progression to kidney failure in children.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf018. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
30. FRIEDRICH J, Bellmann M, Klank D, Porubsky S, et al
    Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.
    Nephrol Dial Transplant. 2024;40:182-192.
    PubMed     Abstract available
    
    
    
31. BUTZ E, Schultheiss UT, Sekula P
    Modeling heterogeneity in the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Dec 19:gfae288. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. GANSEVOORT RT, Wheeler DC, Deben FM, Speeckaert M, et al
    The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
    Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
33. HAHN LUNDSTROM U, Ramspek CL, Dekker FW, van Diepen M, et al
    Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
    Nephrol Dial Transplant. 2024;39:2079-2087.
    PubMed     Abstract available
    
    
    
34. SUENAGA T, Tanaka S, Kitamura H, Tsuruya K, et al
    Estimated potassium intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 27:gfae277. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. DASGUPTA I, Meadowcroft AM, Bhatt PR, Acharya A, et al
    Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2024 Nov 21:gfae273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. DE HAAN A, Eijgelsheim M, Vogt L, Hoorn EJ, et al
    Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
    Nephrol Dial Transplant. 2024 Nov 19:gfae270. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. JOO YS, Yun HR, Kim HW, Koh HB, et al
    Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 15:gfae268. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. JUDGE PK, Tuttle KR, Staplin N, Hauske SJ, et al
    The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. METSARINNE K, Bodegard J, Toppila I, Uusi-Rauva K, et al
    Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022.
    Nephrol Dial Transplant. 2024 Nov 7:gfae242. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
    Noncanonical microglial IL-1beta maturation in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 4:gfae239. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
41. KRAMER A, Jager KJ, Chesnaye NC, Kerschbaum J, et al
    Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.
    Nephrol Dial Transplant. 2024;39:1835-1845.
    PubMed     Abstract available
    
    
    
42. NG MSY, Jones AT, Mallett AJ, O'Shaughnessy MM, et al
    Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014.
    Nephrol Dial Transplant. 2024;39:1846-1855.
    PubMed     Abstract available
    
    
    
43. HAMROUN A, Aymes E, Couchoud C, Bechade C, et al
    Elderly predialysis care pathways and early morbidity-mortality upon start of dialysis.
    Nephrol Dial Transplant. 2024 Oct 18:gfae236. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. DUARTE MP, Nobrega OT, Vogt BP, Pereira MS, et al
    Reference Values for Handgrip Strength, Five Times Sit-to-stand, and Gait Speed in Patients on Hemodialysis.
    Nephrol Dial Transplant. 2024 Oct 16:gfae232. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. COHEN EP, Denic A, Aperna F, Mullan AF, et al
    Stenosis of the glomerulotubular neck in progressive chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 16:gfae234. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. WAGNER CA, Massy ZA, Capasso G, Mattace-Raso F, et al
    Translational research on cognitive impairment in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 14:gfae229. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. ARDAVANI A, Curtis F, Hopwood E, Highton P, et al
    Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2024 Oct 9:gfae221. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. AN S, Qian H, Yang J, Han C, et al
    Cardiac magnetic resonance assessment of cardiac function across chronic kidney disease stages.
    Nephrol Dial Transplant. 2024 Oct 4:gfae222. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
49. BAE S, Chen Y, Sandal S, Lentine KL, et al
    Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
    Nephrol Dial Transplant. 2024 Sep 30:gfae218. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. ZHUANG B, Gan L, Liu B, Yuan W, et al
    Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2024;39:1649-1661.
    PubMed     Abstract available
    
    
    
51. STEL VS, Boenink R, Astley ME, Boerstra BA, et al
    A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.
    Nephrol Dial Transplant. 2024;39:1593-1603.
    PubMed     Abstract available
    
    
    
52. OLIVERAS L, Rosales BM, De La Mata N, Vajdic CM, et al
    Relative survival in patients with cancer and kidney failure.
    Nephrol Dial Transplant. 2024;39:1604-1612.
    PubMed     Abstract available
    
    
    
53. IATRIDI F, Carrero JJ, Gall EC, Kanbay M, et al
    A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
    Nephrol Dial Transplant. 2024 Sep 19:gfae209. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. MAYNE KJ, Sardell RJ, Staplin N, Judge PK, et al
    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Sep 14:gfae203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. MAHBOOBI S, Mollard R, Tangri N, Askin N, et al
    Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2024 Sep 14:gfae200. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. ARANA C, Hermida E, Rovira J, Caro JL, et al
    Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Sep 10:gfae186. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Proactively boosting home dialysis adoption in Europe.
    Nephrol Dial Transplant. 2024 Sep 9:gfae199. doi: 10.1093.
    PubMed    
    
    
    
58. CHO Y, Cullis B, Ethier I, Htay H, et al
    Global structures, practices, and tools for provision of chronic peritoneal dialysis.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    
59. HTAY H, Cho Y, Jha V, See E, et al
    Global structures, practices, and tools for provision of hemodialysis.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    
60. VIECELLI AK, Gately R, Barday Z, Shojai S, et al
    Worldwide organization and structures for kidney transplantation services.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    August 2024
61. ZHANG LY, Dinh A, Johansen KL, McCulloch CE, et al
    Access to kidney transplantation from dialysis facilities affiliated with a transplant center versus free-standing dialysis facilities in the US.
    Nephrol Dial Transplant. 2024 Aug 30:gfae194. doi: 10.1093.
    PubMed    
    
    
    
62. ALUND O, Unwin R, Challis B, Kalra PA, et al
    A note on performance metrics for the Kidney Failure Risk Equation.
    Nephrol Dial Transplant. 2024;39:1523-1525.
    PubMed    
    
    
    
63. SACHEZ-ALAMO B, Moi L, Bajema I, Berden A, et al
    Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2024;39:1483-1493.
    PubMed     Abstract available
    
    
    
64. QUIROGA B, Diez J
    The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.
    Nephrol Dial Transplant. 2024 Aug 30:gfae193. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. PANIAGUA R, Ramos A, Avila M, Ventura MD, et al
    Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial.
    Nephrol Dial Transplant. 2024 Aug 20:gfae188. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. SCHROPPEL B, Bettac L, Schulte-Kemna L, Kachele M, et al
    Placement of tunneled hemodialysis catheters - interventional standard.
    Nephrol Dial Transplant. 2024 Aug 16:gfae181. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. GROSS O, Boeckhaus J, Weber LT, Heerspink HJL, et al
    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.
    Nephrol Dial Transplant. 2024 Aug 9:gfae180. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
68. DONG Y, Wang Z, Guo W, Zhu L, et al
    Association between urinary C4d levels and disease progression in IgA nephropathy.
    Nephrol Dial Transplant. 2024;39:1279-1287.
    PubMed     Abstract available
    
    
    
69. KOMMER A, Kostev K, Schleicher EM, Weinmann-Menke J, et al
    Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 18:gfae135. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. LI Z, Chen S, Tan Y, Lv J, et al
    The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 17:gfae172. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. MAKHLOUFI M, Cottinet PJ, Ranchin B, Dureuil B, et al
    Hemodialysis versus peritoneal dialysis in children: an eco-audit.
    Nephrol Dial Transplant. 2024 Jul 13:gfae159. doi: 10.1093.
    PubMed    
    
    
    
72. COLLISTER D, Pyne L, Bhasin AA, Smyth B, et al
    Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
    Nephrol Dial Transplant. 2024 Jul 10:gfae156. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. FAGUER S, Serre JE, Brusq C, Bongard V, et al
    A randomized crossover trial of regional anticoagulation modalities for intermittent hemodialysis.
    Nephrol Dial Transplant. 2024 Jul 8:gfae155. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. GHIMIRE A, Lloyd AM, Bello AK, Battistella M, et al
    Prescribing patterns and medications costs in patients on maintenance hemodialysis and peritoneal dialysis.
    Nephrol Dial Transplant. 2024 Jul 4:gfae154. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
75. BOGATAJ S, Roelands B, Pajek M, Pajek J, et al
    Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients.
    Nephrol Dial Transplant. 2024;39:1198-1200.
    PubMed    
    
    
    
76. KIM JE, Park J, Jang Y, Kang E, et al
    Oral phosphate binders and incident osteoporotic fracture in patients on dialysis.
    Nephrol Dial Transplant. 2024 Jun 17:gfae139. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. HEERSPINK HJL, Agarwal R, Bakris GL, Cherney DZI, et al
    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
    Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
78. BATTAGLIA Y, Mantovani A, Shroff R, Alfano G, et al
    Online haemodiafiltration and all-cause mortality: how fragile are the results of the studies published so far?
    Nephrol Dial Transplant. 2024;39:1034-1036.
    PubMed    
    
    
    
79. LABRIOLA L, Crott R, Desmet C, Romain C, et al
    Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up.
    Nephrol Dial Transplant. 2024;39:1000-1007.
    PubMed     Abstract available
    
    
    
80. CORTE-IGLESIAS V, Saiz ML, Andrade-Lopez AC, Salazar N, et al
    Propionate and butyrate counteract renal damage and progression to chronic kidney disease.
    Nephrol Dial Transplant. 2024 May 24:gfae118. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Unlocking the Untapped Potential: The Neglected Home Dialysis Assets in Europe.
    Nephrol Dial Transplant. 2024 May 16:gfae111. doi: 10.1093.
    PubMed    
    
    
    
82. KREMER D, Salamah S, Groothof D, Post A, et al
    Plasma Symmetric Dimethylarginine and Kidney Graft Function in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2024 May 15:gfae109. doi: 10.1093.
    PubMed    
    
    
    
83. MCEWAN P, Gabb PD, Davis JA, Sanchez JJG, et al
    The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
    Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. KRAMER A, Boenink R, Mercado Vergara CG, Bell S, et al
    Time trends in preemptive kidney transplantation in Europe: an era registry study.
    Nephrol Dial Transplant. 2024 May 9:gfae105. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. IATRIDI F, Malandris K, Ekart R, Xagas E, et al
    Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study.
    Nephrol Dial Transplant. 2024 May 6:gfae104. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
86. WOLFGRAM DF, Richerson WT, Murray AM, Schmit BD, et al
    Cognitive deficits associate with cerebral hypoxia during hemodialysis.
    Nephrol Dial Transplant. 2024 Apr 30:gfae101. doi: 10.1093.
    PubMed    
    
    
    
87. LEMOINE S, Akbari A, Brahm G, Dorie J, et al
    Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.
    Nephrol Dial Transplant. 2024 Apr 30:gfae070. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. KANBAY M, Basile C, Battaglia Y, Mantovani A, et al
    Shared decision making in elderly patients with kidney failure.
    Nephrol Dial Transplant. 2024;39:742-751.
    PubMed     Abstract available
    
    
    
89. LIAO YR, Tsai YC, Hsieh TH, Tsai MT, et al
    FHL2 in arterial medial calcification in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
    Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
    Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. ZHANG X, Wang G, Li M, Li Y, et al
    Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. 
    Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
    Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
    PubMed    
    
    
    
93. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
    Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
94. ELEFTHERIADIS G, Naik MG, Osmanodja B, Halleck F, et al
    Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Mar 28:gfae076. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
    The safety of a low protein diet in older adults with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. FORBES AK, Hinton W, Feher MD, Elson W, et al
    A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
    Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
    Physical exercise: a polypill against chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. ZHAI S, Liu D, Liu H, Li W, et al
    Cold atmospheric plasma for chronic kidney disease-related skin disorders.
    Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
99. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
    Health-related quality of life and symptom burden in patients on haemodialysis.
    Nephrol Dial Transplant. 2024;39:436-444.
    PubMed     Abstract available
    
    
    
100. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
     A tool to predict the risk of lower extremity amputation in patients starting dialysis.
     Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
     Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
     Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
     PubMed    
     
     
     
103. ADOLI LK, Couchoud C, Chatelet V, Lobbedez T, et al
     Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.
     Nephrol Dial Transplant. 2024 Feb 21:gfae047. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2023
104. DE LA MATA NL, Khou V, Hedley JA, Kelly PJ, et al
     Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
     Nephrol Dial Transplant. 2023 Nov 28:gfad253. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. HARDING JL, Di M, Pastan SO, Doucet N, et al
     Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
     Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.